- IMCAS Asia - June 2024
- IMCAS World Congress - January 2025
- IMCAS Asia - June 2024
- IMCAS World Congress - January 2025

IMCAS Academy

Introduction
Register
Program
Speakers
Gala
Plan your trip
Submit an abstract
Sponsor list
Press

IMCAS Asia 2024
Program

FOCUS ON INDUSTRY SPONSORED E-POSTER

Room: E-Poster Area
Format: OPEN STAGE LIBRARY > e-posters displayed during the whole conference period

Speakers	Lecture title	Abstract	Number
	To be announced (Sponsored by MINERVA THREAD CANNULA NEEDLE)		138758
	Pain mechanisms: A new theory (Sponsored by BEIJING WEILI MEDICAL)		138759
	To be announced (Sponsored by FINEMEC CO., LTD.)		138763
	To be announced (Sponsored by GERMANY MEDICAL)		138764
	To be announced (Sponsored by GERMANY MEDICAL)		138765
	To be announced (Sponsored by OSTEONIC CO.,LTD.)		138770
Dr Thanyawarin CHOTHCHOBPRADIT	A friend of dermal stimulation (Sponsored by DALDAM CO., LTD)	View	138762
Dr Jeong Ho KIM	Effects of Polynucleotide dermal filler in the correction of crow’s feet using an Antera three-dimensional camera (Sponsored by BR PHARM)	View	138757
Dr Christie MOEY	Maximizing aesthetic results with the most powerful Monopolar radiofrequency: clinical techniques and strategies (Sponsored by TENTECH INC)	View	138772
Dr Sarawalai RAKCHART	Age defying Elixir: targeting time's adversaries (Sponsored by BIOLOGIQUE RECHERCHE)		138761
Dr Sarawalai RAKCHART	When science defies senescence (Sponsored by BIOLOGIQUE RECHERCHE)		138760
Elena TARVAINYTE	Revolutionizing lipolysis in South Korea & Japan – The rise of natural Ingredient-based fat dissolving Injections (Sponsored by ENSOR CELL)	View	138769
Dr Yun XIE	Evaluate the efficacy and safety of lidocaine-containing cross-linked sodium hyaluronate gel(MaiLi-E) for chin augmentation treatment (Sponsored by SINCLAIR)	View	138771

Go to next room (Lunch Stations)

To be announced (Sponsored by MINERVA THREAD CANNULA NEEDLE)

Pain mechanisms: A new theory (Sponsored by BEIJING WEILI MEDICAL)

To be announced (Sponsored by FINEMEC CO., LTD.)

To be announced (Sponsored by GERMANY MEDICAL)

To be announced (Sponsored by OSTEONIC CO.,LTD.)

Dr Thanyawarin CHOTHCHOBPRADIT

Thailand

Other author(s) :

A friend of dermal stimulation (Sponsored by DALDAM CO., LTD)

Objectives: The MS-biostimulator
We develop the good shape for the good physiochemical characteristics due to safety and aesthetic considerations creating a workable method for injecting the implant.

Introduction: The MS-biostimulator
We adjust the MICROSHERE from polygonal shape for a suitable distribution and ideal level of inflammation. Fewer complications due to nodule inflammation. We can approach the infraorbital and perioral zone sensitive areas with this product's unique design. But the BS is an operator dependent procedure, so we introduce the proper technique and exchange experiences.

Materials / method: Dilute 10cc
• Good and homogenous Suspension
• Easy to calculate
• Take a short hydrating time

Smooth Linear Retrograde Technique
• 0.3cc / cm2
• Smooth and evenly distribution
• Smas area for lifting
• Anterior of face for tightening

Depth
• Superficial SubQ Layer
• Consistency depth of injection

Results: GOOD CANDIDATE
• Aging
• Sagging
• Less dermal collagen

GOOD DILUTION
• Homogenous suspension
• Adequate product

GOOD TECHNIQUE
• Well trained technique

GOOD TAKE CARE AFTER
• Massage repeat time >8-12wk

Conclusion: A friend of dermal stimulation
MS -PLLA is considered an efficient competent for dermal stimulation. The result examines less cannula occlusion by sediment, optimal inflammatory stimulation and cell response. The outcome for tightening and lifting are satisfactory. Many area of approach less complications

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): DALDAM CO., LTD

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): DALDAM CO., LTD

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): DALDAM CO., LTD

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: DALDAM CO., LTD

Dr Jeong Ho KIM

Dermatologist

South Korea

Other author(s) : Dr Eon Su KIM, Dr Sug Won KIM, Dr Seung Phil HONG, Dr Jiye KIM

Effects of Polynucleotide dermal filler in the correction of crow’s feet using an Antera three-dimensional camera (Sponsored by BR PHARM)

Objectives: In this clinical study, we evaluated the effects of polynucleotide fillers subjectively using CFGS, global esthetic improvement scale (GAIS), and objectively using an Antera 3D camera. The Antera 3D camera is a threedimensional (3D) camera used to evaluate skin objective indicators and measure the texture and color of the skin by reconstructing 3D images. The Antera scoring system is a 3D imaging method that objectively presents images before and after treatment.

Introduction: Wrinkles are a major beauty-related concern faced by middle-aged adults, resulting in a growing demand for procedures for softening or removing wrinkle. Crow's feet are wrinkles spreading from the corner of the eyes and are naturally developed owing to the loss of collagen and elastic tissue in the skin with aging. The use of injectable agents has increased over recent years because of the demand for minimally invasive techniques and their simplicity. Recently, dermal fillers have received considerable interest in tissue enlargement and skin improvement.

Materials / method: This study was conducted at Wonju Severance Christian Hospital, Wonju, Korea. It involved 30 healthy volunteers aged 19-60 years with crow's feet grading score (CFGS) of 2-4 points. The exclusion criteria were as follows: received facial rejuvenation therapy (e.g., botulinum toxin and filler), history of skin disorder, immune disease, currently pregnant, and lactating. All subjects voluntarily participated in the study and were allowed to discontinue at any time during the study. The subjects provided written informed consent for the publication and use of their images.

Results: Figure 4 shows the photographs of crow's feet at baseline (v2) and 18 weeks (v8) after the first treatment with polynucleotide filler. Figure 5 shows the Antera 3D images of the crow's feet at baseline and 18 weeks after the first procedure.

Conclusion: In addition to improving crow's feet around the eyes, polynucleotide filler was observed to facilitate the improvement of pores, texture, and skin tone. Such activities are considered to enhance skin quality as well as wrinkles, in shallow wrinkles, such as around the eyes. Nevertheless, further prospective, larger, randomized, and controlled investigations are required to confirm our findings and to optimize polynucleotide filler injection in patient with severe crow's feet wrinkles for enhanced results.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): BR PHARM

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): BR PHARM

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: BR PHARM

Dr Christie MOEY

Malaysia

Other author(s) :

Maximizing aesthetic results with the most powerful Monopolar radiofrequency: clinical techniques and strategies (Sponsored by TENTECH INC)

Objectives: The primary objectives of this comparative analysis are:
1. To evaluate the effectiveness of delivering 300 shots in a single session on one side of the face versus 100 shots per session for three sessions with one-moth intervals on the contralateral side, assessing their respective contributions to skin lifting and tightening.
2. To compare the efficacy of two delivering methods – gliding and stamping,
in achieving optimal results with monopolar RF treatment.
3. To determine the optimal energy level for monopolar RF treatment,
considering its influence on skin lifting and tightening.
4. To as

Introduction: With the growing popularity of non-invasive skin rejuvenation procedures, monopolar radiofrequency (RF) treatment has
emerged as a promising modality for skin lifting and tightening. This study aims to contribute to the existing knowledge by
conducting a split-face investigation into the impact of varying treatment parameters on the efficacy and safety of monopolar RF.

Materials / method: A rigorous split-face study design was employed, with each participant undergoing different treatments on opposing sides of the face. Parameters such as the number of shots per session, delivery method (gliding vs. stamping), energy levels, and mode of operation (Standard vs. Comfort) were systematically varied and evaluated.

Results: Results of this study revealed several key findings. Firstly, higher energy levels were associated with better aesthetic outcomes, with immediate results favoring higher energy settings. Additionally, anatomical asymmetry or variation among participants had a notable impact on treatment outcomes. Furthermore, real-time energy delivery on the patient’s skin differed between Standard and Comfort modes, indicating the influence of prolonged cooling times on energy delivery. The stamping method was found to yield superior results compared to gliding method at equivalent energy levels, albeit with

Conclusion: This comprehensive comparative analysis utilizes diverse evaluation methods, providing a thorough understanding of the nuanced factors influencing the effectiveness and safety of monopolar RF treatment. These findings offer valuable guidance for clinicians and practitioners in optimizing treatment protocol for
non-invasive skin rejuvenation.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): TENTECH INC

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): TENTECH INC

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: TENTECH INC

Dr Sarawalai RAKCHART

Dermatologist

Thailand

Other author(s) :

Age defying Elixir: targeting time's adversaries (Sponsored by BIOLOGIQUE RECHERCHE)

Dr Sarawalai RAKCHART

Dermatologist

Thailand

Other author(s) :

When science defies senescence (Sponsored by BIOLOGIQUE RECHERCHE)

Objectives: To assess the long term efficacy of a multi- ingredient anti-aging serum in improving the following paramenter: 1) firmness 2) Elasticity 3) skin barrier integrity 4) Cell renewal stimulation 5) Collagen synthesis improvement

Introduction: The serum with an enduring promise: to defy the visible signs of skin senescence. Every drop of this serum is a step towards an experiment that defies the limits of senescence thanks to science. Its unique, avant-garde formula offers dual action thanks to 2 powerful vectors:

Progescence®
which reduces the accumulation of senescent cells over time.

Pro-KL®
which delays skin senescence

Materials / method: Inhibition of progerin formation by analog of serine proteinase inhibitor in dermal fibroblasts and keratinocytes. Activation of klotho synthesis by chemical molecules
from plant extract that activates the expression of the gene KL and the related protein Klotho in dermal fibroblasts.

Conclusion: Aging is associated with inevitable accumulation of senescent calls.
Progescence and Pro-KL can slowdown cellular senescence both relicative senescence and premature or stress- induced senscence.

Cellular senescence is an irreversible state in which
cells stop dividing. Excessive accumulation of senescent cells in tissue can adversely affect its regenerative ability, creating a pro-intlammatory environment conducive to the onset and progression of various age-related diseases. The skin si no exception to this observation either.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): BIOLOGIQUE RECHERCHE

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): BIOLOGIQUE RECHERCHE

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: BIOLOGIQUE RECHERCHE

Elena TARVAINYTE

Industry Representative

South Korea

Other author(s) :

Revolutionizing lipolysis in South Korea & Japan – The rise of natural Ingredient-based fat dissolving Injections (Sponsored by ENSOR CELL)

Objectives: Introduce natural ingredients found in fat dissolvinginjections. Evaluate the differences betweendeoxycholic acid-based fat dissolving solutions andnatural ingredient-based fat dissolving solutions.Highlight the reasons why there is a preference fornatural ingredient-based injections in South Korea& Japan.

Introduction: In the cosmetics industry, there is an increasinglystrong preference for natural ingredients overchemical ones, a trend that is also impacting the aesthetic market. However, not all naturalingredients are equally beneficial. Certainsubstances, such as deoxycholic acid, are known tocause unpleasant side effects. Due to theseconcerns, there is a noticeable shift in Korea andJapan from deoxycholic acid-based injections tothose that utilize safer, natural ingredients forlipolysis

Materials / method: Before and after pictures to show differences in sideeffects between deoxycholic acid-based fatdissolving solutions and natural ingredient-basedfat dissolving solutions.

Results: Lipolysis injections based on natural ingredientsboast high safety and low rates of side effects.Although the efficacy may be somewhat lowercompared to products containing deoxycholic acid,the reduced side effects lead to higher customersatisfaction and allow for shorter intervals betweentreatments.

Conclusion: From the customer's perspective, the reduced riskof side effects enhances accessibility to treatments,and from the clinic's standpoint, an increase intreatment frequency improves profitability.Therefore, there is a clear advantage to usinglipolysis injections made with natural ingredients.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): ENSOR CELL

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): ENSOR CELL

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: ENSOR CELL

Dr Yun XIE

Plastic Surgeon

China

Other author(s) : Qingfeng Li, Yi Zhao, Dian Chen, Wei Lai, Zijian Gong, Hang Wang, Hongyi Zhao, Rongxin Ren, Jinnping Ding, Nan Dai, Meng Yan, Fei Qin, Zhongxing Zhang

Evaluate the efficacy and safety of lidocaine-containing cross-linked sodium hyaluronate gel(MaiLi-E) for chin augmentation treatment (Sponsored by SINCLAIR)

Objectives: The lower face is a significant aspect of the overall facial structure, reflecting the physiognomic characteristics of an individual, with the chin contour being a primary
factor influencing facial aesthetics.

As individuals age, the lower face undergoes gradual aging, leading to the appearance of skin laxity and subcutaneous tissue relaxation[1-3].

Chin augmentation using cross-linked hyaluronic acid(HA) injectables can effectively enhance facial appearance.

Introduction: In both men and women, having a well-defined chin is widely regarded as a hallmark of beauty and can significantly impact an individual's psychological and social well-being.

Ideally, the height of the chin should constitute around two-thirds of the lower facial area, and its projection should align with the pogonion meeting the perpendicular line from the nasion[4].

Hyaluronic acid (HA) injections have been extensively used for over a decade to augment chins and rejuvenate facial appearance, with a well-established track record of safety and efficacy[5-7].

Materials / method: This is a prospective, multicenter, randomized, no-treatment controlled, investigator blinded, superiority clinical trial (ChiCTR2200063817).

Between September 2022 to January 2024, 159 subjects with chin retrusion were randomized (2?1) in the test group (n=106) and in the no-treatment control group (n=53).

Response rate of chin augmentation at different visits ( at 6 month as assessed by third party independent investigators and at 1,3,6,9, 12 month as assessed by injection investigators) and GAIS scores as assessed by subjects were evaluated as efficacy endpoints.

Results: Response rates of chin augmentation improvement at 6 month (assessed by third-party independent blinded investigators)

Response rate of chin augmentation improvement in test group at 6 month after the last injection (assessed by a third-party independent blinded investigator) were 64.2%(95%Cl: 55.0%, 73.3%) , while in the control group were 20.8%(95%Cl: 9.8%, 31.7%) . The treatment was effective.

Response rates of chin augmentation improvement (assessed by injection investigators)

The test group exhibited a significantly higher improvement rate in chin augmentation compared to the control

Conclusion: Our findings suggest that the test medical device(MaiLi-E) was significantly more efficacious than the control group in chin augmentation at 1,3, and 6 month after treatment, and the test device efficacy maintained up to 12 month after treatment.

Additionally, the GAIS scores of subjects in the test group were significantly lower(better) than those in the control group at 1, 3, and 6 month following the last injection.

During the clinical trial, the test group was equivalent to the control group in terms of the incidences of various AEs, without device defects reported.

Disclosures

Did you receive any funding to support your research for this TOPIC?
Yes
Please specify entities (individual, company, society): SINCLAIR

Were you provided with any honoraria, payment or other compensation for your work on this study?
Yes
Please specify entities (individual, company, society): SINCLAIR

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: SINCLAIR

CONGRESS in

0 2 0

DAYS IN BANGKOK

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS Asia
IMCAS World Congress

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS Asia 2024 Program

FOCUS ON INDUSTRY SPONSORED E-POSTER

IMCAS Asia 2024
Program